News · 18 November 2026

FDA approves Pfizer drug combo for more men with prostate cancer

18 November 2026 · Health · US · Uplifting

FDA approves Pfizer drug combo for more men with prostate cancer
Picture: Medscape · Medscape lead image · unknown

The FDA has approved Pfizer's drug talazoparib, taken with enzalutamide, for more men with prostate cancer. It now covers men whose cancer has spread but still responds to hormone therapy. Patients need certain gene mutations. In a trial of 599 men, it cut the risk of the cancer worsening or death by 52%. Anemia was the top serious side effect.

Where this came from. One outlet reported this. We read it, then wrote the sixty words above.

Also on 18 November 2026